🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chosa Oncology AB (FRA:W5L)
Germany flag Germany · Delayed Price · Currency is EUR
0.0392
+0.0062 (18.79%)
At close: Nov 18, 2026

Chosa Oncology AB Statistics

Total Valuation

FRA:W5L has a market cap or net worth of EUR 3.58 million. The enterprise value is 3.35 million.

Market Cap3.58M
Enterprise Value 3.35M

Important Dates

The next estimated earnings date is Tuesday, November 24, 2026.

Earnings Date Nov 24, 2026
Ex-Dividend Date n/a

Share Statistics

FRA:W5L has 91.44 million shares outstanding. The number of shares has increased by 23.85% in one year.

Current Share Class 91.44M
Shares Outstanding 91.44M
Shares Change (YoY) +23.85%
Shares Change (QoQ) -1.37%
Owned by Insiders (%) 8.18%
Owned by Institutions (%) 9.01%
Float 56.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 1.75
P/TBV Ratio 3.12
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.06, with zero debt.

Current Ratio 2.06
Quick Ratio 2.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -37.75% and return on invested capital (ROIC) is -27.55%.

Return on Equity (ROE) -37.75%
Return on Assets (ROA) -24.67%
Return on Invested Capital (ROIC) -27.55%
Return on Capital Employed (ROCE) -38.73%
Weighted Average Cost of Capital (WACC) 13.32%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -91,576
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 1.65, so FRA:W5L's price volatility has been higher than the market average.

Beta (5Y) 1.65
52-Week Price Change -62.50%
50-Day Moving Average 0.04
200-Day Moving Average 0.06
Relative Strength Index (RSI) 45.89
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -668,395
Pretax Income -663,879
Net Income -572,303
EBITDA -600,411
EBIT -668,395
Earnings Per Share (EPS) -0.01
Full Income Statement

Balance Sheet

The company has 231,197 in cash and no debt, with a net cash position of 231,197 or 0.00 per share.

Cash & Cash Equivalents 231,197
Total Debt n/a
Net Cash 231,197
Net Cash Per Share 0.00
Equity (Book Value) 1.73M
Book Value Per Share 0.02
Working Capital 187,757
Full Balance Sheet

Cash Flow

Operating Cash Flow -505,995
Capital Expenditures n/a
Depreciation & Amortization 67,499
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

FRA:W5L does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -23.85%
Shareholder Yield -23.85%
Earnings Yield -19.74%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2